Femasys, Inc. (FEMY)
1.75
-0.25
(-12.50%)
USD |
NASDAQ |
Oct 12, 16:00
1.76
+0.01
(+0.57%)
After-Hours: 20:00
Femasys Profit Margin (Quarterly) : -1.35K% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.35K% |
| March 31, 2026 | 77.34% |
| December 31, 2025 | -485.7% |
| September 30, 2025 | -575.1% |
| June 30, 2025 | -1.12K% |
| March 31, 2025 | -1.73K% |
| December 31, 2024 | -881.0% |
| September 30, 2024 | -974.8% |
| June 30, 2024 | -2.11K% |
| March 31, 2024 | -1.33K% |
| December 31, 2023 | -2.07K% |
| September 30, 2023 | -1.64K% |
| June 30, 2023 | -902.8% |
| Date | Value |
|---|---|
| March 31, 2023 | -1.00K% |
| December 31, 2022 | -1.24K% |
| September 30, 2022 | -858.4% |
| June 30, 2022 | -869.1% |
| March 31, 2022 | -897.0% |
| December 31, 2021 | -930.0% |
| September 30, 2021 | -838.2% |
| June 30, 2021 | -332.2% |
| March 31, 2021 | -554.9% |
| December 31, 2020 | -590.6% |
| September 30, 2020 | -500.7% |
| June 30, 2020 | -810.9% |
| March 31, 2020 | -845.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
| Baxter International, Inc. | 4.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -264.2% |
| Return on Assets | -77.19% |
| Return on Invested Capital | -114.3% |
| Gross Profit Margin (Quarterly) | -2.41% |
| Operating Margin (Quarterly) | -1.53K% |
| Return on Net Operating Assets | -130.9% |